top of page
Platelet BioGenesis is developing technology to produce the world’s first donor-independent human platelets from human induced pluripotent stem cells. This technology will bridge the gap from megakaryocyte to platelet. Platelets are the ‘bandaids’ of the bloodstream, responsible for clot formation and blood vessel repair. Over 2 million Americans receive platelet transfusions annually that dramatically increase survival rates for cancer, transplant, and surgery patients.
bottom of page